Cancer Trials: Patient-Reported Outcomes Should Measure Five Core Concepts, US FDA Says

 
• By Sue Sutter
  
Apple core
US FDA has suggested a set of core concepts on which it would like to see PRO data from cancer registrational trials. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D